Skip to content

HD Sense Pilot Study - A Novel Method of Hemodynamic Monitoring

A Novel Method of Hemodynamic Monitoring by Piezocapacitative Interlayer Sensor Technology - A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03263988
Enrollment
39
Registered
2017-08-28
Start date
2017-10-19
Completion date
2019-12-31
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability

Keywords

pulse contour analysis, capton, intraoperative monitoring

Brief summary

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available.

Detailed description

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available. For this reason all patients will get a basic monitoring (NIBP, ECG, SpO2)

Interventions

DEVICEConCardiac

All patients receive a piezocapacitative-interlayer-technology hemodynamic measurement by ConCardiac device (SectorCon GmbH, Berlin, Germany).

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* elective surgery and general anesthesia * age \>/= 18 years * any surgery in ENT/trauma/gynecology/visceral surgery/thoracic surgery/urology/neuro surgery/cardio surgery (N=10) * cardio surgery (N=10) * Transcatheter Aortic Valve Implantation (N=20) * cystectomy (N=10) * neurosurgery with an expected postoperative ICU stay \>/= 20 hours (N=10)

Exclusion criteria

* pregnant or breastfeeding patients * emergency surgery * participation in a clinical interventional study * BMI \>35 kg/m² * impossibility to place the ConCardiac interlayer * difference of blood pressure of right and left arm \> 12 mmHg * pAVK Fontaine IV * arrythmia absoluta * vitium cordis \>/=3 * ejection fraction \<35% * TAPSE \</=16mm * need of IABP

Design outcomes

Primary

MeasureTime frameDescription
PPVDuration of surgery and perioperative care (an average of 24 hours)Percentual error of PPV \< 30% for ConCardiac between ConCardiac and PICCO

Secondary

MeasureTime frameDescription
Duration of anesthesiaDuration of surgery (an average of 4 hours)
intraoperative blood lossDuration of surgery and perioperative care (an average of 24 hours)
Duration of mechanical ventilationDuration of surgery (an average of 4 hours)
Duration of renal replacement therapyperioperative (an average of 10 days)
Length of hospital stayperioperative (an average of 10 days)
Blood products and volume needed perioperativeperioperative (an average of 10 days)
ICU scores (TISS)perioperative (an average of 10 days)
ICU scores (SOFA)perioperative (an average of 10 days)
ICU scores (SAPS)perioperative (an average of 10 days)
Incidence of organ failure or complicationsperioperative (an average of 10 days)
Vital signs of patients/blood pressureperioperative (an average of 10 days)RR
Vital signs of patients/heart frequencyperioperative (an average of 10 days)HF
Duration of surgeryDuration of surgery (an average of 4 hours)
Vital signs of patients/stroke volumeperioperative (an average of 10 days)SV
Vital signs of patients/pulse pressure variationperioperative (an average of 10 days)PPV
Vital signs of patients/systemic vascular resistance indexperioperative (an average of 10 days)SVRI
Vital signs of patients/intrathoracic blood volume indexperioperative (an average of 10 days)ITBV/I
Vital signs of patients/extra vascular lung water indexperioperative (an average of 10 days)ELWI
Vital signs of patients/global enddiastolic volume indexperioperative (an average of 10 days)GEDI
Vital signs of patients/Ventilator settingsperioperative (an average of 10 days)Ventilator settings
Vital signs of patients/blood gasesperioperative (an average of 10 days)BGA
Vital signs of patients/creatinineperioperative (an average of 10 days)Creatinine
Vital signs of patients/central venous oxygen saturationperioperative (an average of 10 days)ScvO2
Vital signs of patients/central venous pressureperioperative (an average of 10 days)CVP
Vital signs of patients/diuresisperioperative (an average of 10 days)Diuresis
Vital signs of patients/Cardiac indexperioperative (an average of 10 days)CI

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026